| Renovascular hypertension: an update. | |
| | |
MedLine Citation:
|
PMID: 18607138 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Renovascular hypertension, the most common remediable cause of elevated blood pressure, is a controversial topic, but most authorities agree on several principles. The absolute risk of renovascular hypertension for a specific patient can be estimated using only clinical information, thereby sparing many patients further expensive and potentially dangerous evaluations. Patients with a high absolute risk of renovascular hypertension should have angiography only if they are willing to undergo revascularization if warranted. A screening test (captopril renography, Doppler ultrasonography, magnetic resonance angiography, or computed tomography) is recommended for those with an intermediate absolute risk. Angioplasty should be offered to patients with fibromuscular dysplasia. Whether intensive medical therapy (including an angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker) for atherosclerotic renovascular hypertension is improved by angioplasty plus stent placement may be answered by ongoing studies, the largest of which may be the National Institutes of Health-funded Cardiovascular Outcomes in Renal Atherosclerotic Lesions (CORAL) trial. |
| | |
Authors:
|
William J Elliott |
Related Documents
:
|
3621538 - Identification of risk factors for spinal cord ischemia by the use of monitoring of som... 2964188 - Balloon angioplasty for coarctation of the aorta: immediate and long-term results. 6625638 - Expiration induced femoral flow in neonatal coarctation of aorta. 12554338 - A novel aortic coarctation model for studying hypertension in the pig. 10641678 - Scaling of turbulent wall pressure fluctuations downstream of a rearward facing step. 7441548 - Phase relationship between normal human respiration and baroreflex responsiveness. |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Journal of clinical hypertension (Greenwich, Conn.) Volume: 10 ISSN: 1524-6175 ISO Abbreviation: J Clin Hypertens (Greenwich) Publication Date: 2008 Jul |
Date Detail:
|
Created Date: 2008-07-08 Completed Date: 2008-10-24 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100888554 Medline TA: J Clin Hypertens (Greenwich) Country: United States |
Other Details:
|
Languages: eng Pagination: 522-33 Citation Subset: IM |
Affiliation:
|
Department of Preventive Medicine, Rush Medical College, Rush University Medical Center, Chicago, IL 60612, USA. welliott@rush.edu |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Angioplasty, Balloon Angiotensin II Type 1 Receptor Blockers / therapeutic use Angiotensin-Converting Enzyme Inhibitors / therapeutic use Antihypertensive Agents / therapeutic use* Humans Hypertension, Renovascular* / diagnosis, drug therapy, epidemiology, physiopathology Magnetic Resonance Angiography Prevalence Risk Factors United States / epidemiology |
| Chemical | |
Reg. No./Substance:
|
0/Angiotensin II Type 1 Receptor Blockers; 0/Angiotensin-Converting Enzyme Inhibitors; 0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Spontaneously migrated tip of an implantable port catheter into the axillary vein in a patient with ...
Next Document: Endocrine causes of secondary hypertension.